Dr
Jade
Cheng

Patent Attorney

London Office

Life sciences

Telephone. +44 (0)207 776 5100
Email. [email protected]

Experience

Jade joined the Life Sciences group of HGF in February 2022 as a qualified UK and European Patent Attorney.

Prior to being a Patent Attorney, Jade was a postdoctoral fellow at the Medical Research Council Laboratory of Molecular Biology (MRC LMB) in Cambridge. During her time as an academic, she investigated diverse subjects including the blood brain barrier, mechanisms of cell death and embryonic development.

Jade’s experience in academia means she understands the patenting process from academics' point of view and is ideally placed to work alongside universities’ technology transfer departments and their academics.

Jade’s main areas of focus in patent practice are on antibodies, vaccines and medical treatments. She has experience with drafting and filing applications, prosecution, freedom-to-operate analyses, third party observations, EPO oppositions and appeals, and providing filing strategies. She also advises clients on prosecution in many foreign jurisdictions.

Jade enjoys being a member of the HGF Venture team with Kerry Rees to provide IP due diligence services to life science investors. As a consequence, Jade also works with early stage companies to help them align their IP strategies with their business plan to maximum the return on investment.

Jade is fluent in English and Cantonese.

Qualifications

Patent Attorney

Chartered (UK)
European


BSC

Biochemistry

PHD

Biochemistry

Related News

Patentability of Simulations in Europe

Simulations offer a powerful tool in modern-day engineering. Subjecting designs to initial testing in a simulated environment will, for many designs, reduce costs owing to reduced needs to produce and …

Read article

Blockbuster blood thinning patent revoked

Summary Mr Justice Meade has revoked Bristol Myers Squibb’s (BMS) European patent No. EP1427415 (EP’415) and corresponding supplementary protection certificate (SPC) that relate to the compound Apixaban (ELIQUIS) for lack …

Read article
Event - 10th May 2022

The HGF IP in Healthcare Conference 2022

After a challenging couple of years, we are delighted to invite you to join us for HGF’s eighth annual IP in Healthcare Conference. We will review the latest intellectual property …

Event details
Event - 10th May 2022

HGF UPC events in Germany and Austria 2022

HGF is holding a webinar and an in-person event covering the UPC in Germany and Austria this Spring. The provisional phase of the Unified Patent Court (UPC) is now underway …

Event details
Event - 23rd March 2022

HGF webinar: Getting your first filing right

HGF hosted a webinar on Wednesday 23rd March on Getting your first filing right. One of the most often asked questions of patent attorneys is: “when should we file?” Both …

Event details
Event - 10th March 2022

Manufacturing & Supply Chain Conference 2022

HGF Patent Attorney Dr Robert Weinert-Aplin is attending and speaking at the Manufacturing & Supply Chain Conference on 10th March 2022 in Milton Keynes, UK. The Manufacturing & Supply Chain …

Event details

The Microbiome Times: ELIGO v SNIPR: a reflection on IP strategies in a competitive environment

HGF Partner and Patent Attorney Craig Thomson and Patent Director Dr Jennifer Bailey write an article for The Microbiome Times on ELIGO v SNIPR: a reflection on IP strategies in …

Read article

UPC could open its doors in 2022

With news that the Austrian parliament has ratified the Protocol on the provisional application of the Agreement on a Unified Patent Court on 2 December 2021, the Unified Patent Court …

Read article

Let's talk

If you would like to discuss how HGF could help you, contact one of our IP specialists.